Divalproex Sodium
NDC Package 0904-6364-45

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Divalproex Sodium is a medication used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. Marketed by Major Pharmaceuticals, this product is identified by NDC 0904-6364 and is authorized under FDA application ANDA090070.

Identification & Billing

NDC Package Code
0904-6364-45
Package Description
80 BLISTER PACK in 1 CARTON / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Product Code
11-Digit Billing Format
00904636445
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
80 EA

Clinical Specifications

Proprietary Name
Divalproex Sodium
Dosage Form
-
Usage Information
This medication is used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. It works by restoring the balance of certain natural substances (neurotransmitters) in the brain.

Regulatory & Marketing

Labeler Name
Major Pharmaceuticals
FDA Application #
ANDA090070
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-11-2013
End Marketing Date
02-29-2024
Listing Expiration
02-29-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0904-6364). Click a package code to view its specific billing and regulatory data.

100 BLISTER PACK in 1 CARTON / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0904-6364-45 identifies a specific commercial package of 80 blister pack in 1 carton / 1 tablet, extended release in 1 blister pack of Divalproex Sodium, labeled by Major Pharmaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Major Pharmaceuticals on August 11, 2013. The current certification is valid through February 29, 2024.

What are the primary indications for this medication?

This medication is used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. It works by restoring the balance of certain natural substances (neurotransmitters) in the brain.

How is this Major Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00904636445. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 80 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0904-6364-45
11-Digit CMS (5-4-2)
00904-6364-45

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.